StockData
Nexalin Technology, Inc. logo

Nexalin Technology, Inc. (NXL) stock

NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.44−0.06 (-4.00%)

Close on Nov 18, 2026Market cap $31.73MP/E –Yield –

Nexalin Technology price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Nexalin Technology's price to sales ratio was 161.1× on Nov 11, 2026, against 182.8× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026161.1×+54.6
2024Feb 29, 2024106.5×−29.7
2023Dec 29, 2023136.2×+11.0
2022Dec 30, 2022125.2×–

More Nexalin Technology figures

See a number that looks wrong?